Briacell Therapeutics logo

Briacell Therapeutics Share Price (NASDAQ: BCTX)

$7.82

0.52

(7.12%)

Last updated on

Check the interactive Briacell Therapeutics Stock chart to analyse performance

Briacell Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$7.28
    Today's High:$7.84

    Day's Volatility :7.12%

  • 52 Weeks Low:$6.00
    52 Weeks High:$294.00

    52 Weeks Volatility :97.96%

Briacell Therapeutics Stock Returns

PeriodBriacell Therapeutics CorpIndex (Russel 2000)
3 Months
-77.58%
0.0%
6 Months
-76.06%
0.0%
1 Year
-92.68%
0.0%
3 Years
-99.36%
-4.1%

Briacell Therapeutics Corp Key Stats

Check Briacell Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$7.3
Open
$7.38
Today's High
$7.84
Today's Low
$7.282
Market Capitalization
$13.3M
Today's Volume
$49.4K
52 Week High
$294.0
52 Week Low
$6.0
Revenue TTM
$0.0
EBITDA
$-24.3M
Earnings Per Share (EPS)
$-76.9
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-688.17%

Stock Returns calculator for Briacell Therapeutics Stock including INR - Dollar returns

The Briacell Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Briacell Therapeutics investment value today

Current value as on today

₹12,644

Returns

₹87,356

(-87.36%)

Returns from Briacell Therapeutics Stock

₹92,640 (-92.64%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Briacell Therapeutics Stock

-69%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Briacell Therapeutics Stock from India on INDmoney has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Briacell Therapeutics Corp

  • Name

    Holdings %

  • UBS Group AG

    0.01%

Analyst Recommendation on Briacell Therapeutics Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Briacell Therapeutics(by analysts ranked 0 to 5 stars)

Briacell Therapeutics Share Price Target

What analysts predicted

Upside of 1818.16%

Target:

$150.00

Current:

$7.82

Briacell Therapeutics share price target is $150.00, a slight Upside of 1818.16% compared to current price of $7.82 as per analysts' prediction.

Briacell Therapeutics Stock Insights

  • Price Movement

    In the last 7 days, BCTX stock has moved up by 11.5%
  • BCTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 163.3%
  • BCTX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.0% return, outperforming this stock by 215.3%

Briacell Therapeutics Technicals Summary

Sell

Neutral

Buy

Briacell Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Briacell Therapeutics Corp Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Briacell Therapeutics Corp logo
4.57%
-76.06%
-92.68%
-99.36%
-98.67%
Regeneron Pharmaceuticals, Inc. logo
3.92%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
2.49%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-15.42%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
11.08%
83.28%
75.87%
111.28%
242.25%

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Organization
Briacell Therapeutics
Employees
0
CEO
Dr. William V. Williams FCPA, M.D.
Industry
Miscellaneous

Key Management of Briacell Therapeutics Corp

NameTitle
Dr. William V. Williams FCPA, M.D.
CEO, President & Director
Mr. Gadi Levin B.Com., C.A., CPA, M.B.A.
CFO & Corporate Secretary
Dr. Miguel A. Lopez-Lago Ph.D.
Chief Scientific Officer
Dr. Giuseppe Del Priore M.D., M.P.H., MPH
Chief Medical Officer
Dr. Charles Louis Wiseman FACP, M.D.
Founder, Principal Research Advisor & Member of Scientific Advisory Board

Important FAQs about investing in BCTX Stock from India :

What is Briacell Therapeutics share price today?

Briacell Therapeutics share price today is $7.82 as on at the close of the market. Briacell Therapeutics share today touched a day high of $7.84 and a low of $7.28.

What is the 52 week high and 52 week low for Briacell Therapeutics share?

Briacell Therapeutics share touched a 52 week high of $294.00 and a 52 week low of $6.00. Briacell Therapeutics stock price today i.e. is closed at $7.82, lower by 97.34% versus the 52 week high.

How to invest in Briacell Therapeutics Stock (BCTX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Briacell Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Briacell Therapeutics Shares that will get you 0.1918 shares as per Briacell Therapeutics share price of $7.82 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Briacell Therapeutics Stock (BCTX) from India?

Indian investors can start investing in Briacell Therapeutics (BCTX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Briacell Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Briacell Therapeutics share’s latest price of $7.82 as on August 30, 2025 at 1:29 am IST, you will get 1.2788 shares of Briacell Therapeutics. Learn more about fractional shares .

What are the returns that Briacell Therapeutics has given to Indian investors in the last 5 years?

Briacell Therapeutics stock has given -98.67% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?